Next Article in Journal
Disease Biomarkers in the Precision Medicine Era: A Comprehensive Multi-Omics Analysis
Previous Article in Journal
Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review of Prevalence, Clinical Phenotype, and Surgical Outcomes
Previous Article in Special Issue
Behavioral Phenotyping of WAG/Rij Rat Model of Absence Epilepsy: The Link to Anxiety and Sex Factors
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 13
Issue 9
10.3390/biomedicines13092216
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Biomedicines 2025, 13(2), 512.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512

by
Uros Velickovic
1,
Dragica Selakovic
1,*,
Nemanja Jovicic
2,
Marina Mitrovic
3,
Vladimir Janjic
4,5,
Sara Rosic
1,
Suzana Randjelovic
6,
Dragan Milovanovic
7 and
Gvozden Rosic
1
1
Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
2
Department of Histology and Embryology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
3
Department of Medical Biochemistry, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
4
Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
5
Psychiatry Clinic, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia
6
Department of Emergency Medicine, University Clinical Center Kragujevac, 34000 Kragujevac, Serbia
7
Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia
*
Author to whom correspondence should be addressed.
Biomedicines 2025, 13(9), 2216; https://doi.org/10.3390/biomedicines13092216
Submission received: 22 August 2025 / Accepted: 28 August 2025 / Published: 10 September 2025
(This article belongs to the Special Issue Animal Models of Neurological Disorders: Where Are We Now? (2nd Edition))
Versions Notes
The authors would like to make the following corrections to this published paper [1]:
Instead of the following retracted Ref. [24] in the paper:
Taylor, D.M.; Velaga, S.; Werneke, U. Reducing the stigma of long acting injectable antipsychotics—Current concepts and future developments. Nord. J. Psychiatry 2018, 72 (Suppl. S1), S36–S39.
We have now included the following [2]:
Nadesalingam, N.; Chapellier, V.; Lefebvre, S.; Pavlidou, A.; Stegmayer, K.; Alexaki, D.; Gama, D.B.; Maderthaner, L.; von Känel, S.; Wüthrich, F.; et al. Motor abnormalities are associated with poor social and functional outcomes in schizophrenia. Comp. Psychiatry 2022, 115, 152307.
There are no changes to the order of references. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Velickovic, U.; Selakovic, D.; Jovicic, N.; Mitrovic, M.; Janjic, V.; Rosic, S.; Randjelovic, S.; Milovanovic, D.; Rosic, G. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512. [Google Scholar] [CrossRef] [PubMed]
  2. Nadesalingam, N.; Chapellier, V.; Lefebvre, S.; Pavlidou, A.; Stegmayer, K.; Alexaki, D.; Gama, D.B.; Maderthaner, L.; von Känel, S.; Wüthrich, F.; et al. Motor abnormalities are associated with poor social and functional outcomes in schizophrenia. Comp. Psychiatry 2022, 115, 152307. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Velickovic, U.; Selakovic, D.; Jovicic, N.; Mitrovic, M.; Janjic, V.; Rosic, S.; Randjelovic, S.; Milovanovic, D.; Rosic, G. Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512. Biomedicines 2025, 13, 2216. https://doi.org/10.3390/biomedicines13092216

AMA Style

Velickovic U, Selakovic D, Jovicic N, Mitrovic M, Janjic V, Rosic S, Randjelovic S, Milovanovic D, Rosic G. Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512. Biomedicines. 2025; 13(9):2216. https://doi.org/10.3390/biomedicines13092216

Chicago/Turabian Style

Velickovic, Uros, Dragica Selakovic, Nemanja Jovicic, Marina Mitrovic, Vladimir Janjic, Sara Rosic, Suzana Randjelovic, Dragan Milovanovic, and Gvozden Rosic. 2025. "Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512" Biomedicines 13, no. 9: 2216. https://doi.org/10.3390/biomedicines13092216

APA Style

Velickovic, U., Selakovic, D., Jovicic, N., Mitrovic, M., Janjic, V., Rosic, S., Randjelovic, S., Milovanovic, D., & Rosic, G. (2025). Correction: Velickovic et al. The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation. Biomedicines 2025, 13, 512. Biomedicines, 13(9), 2216. https://doi.org/10.3390/biomedicines13092216

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop